Therapeutics News and Research

RSS

ASU study explores components of the immune system

Unless you are an identical twin, you probably aren't often mistaken for someone else. Likewise, our own sense of self as distinct from all other humans is deeply ingrained since early childhood.

2 Jun 2022

New research may open a window to treating aggressive form of B-cell acute lymphoblastic leukemia

Survival has improved greatly in children with acute lymphocytic leukemia (ALL). But a certain form of ALL that occurs mostly in babies is still very lethal, with a survival rate below 50 percent: B-cell acute lymphoblastic leukemia with rearrangements of the mixed lineage leukemia gene, or MLL B-ALL.

1 Jun 2022

Study finds a link between aging and cancer metastases

Spreading cancer cells that escape a primary tumor site can seed in tissues distant from the tumor, but may take several years or decades to grow into full metastatic cancers.

1 Jun 2022

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

Researchers hypothesized that the emergence of resistant SARS-CoV-2 variants can be anticipated by identifying possible escape mutations already present in the existing SARS-CoV-2 populations.

1 Jun 2022

Study highlights the positive effects of Humanin G in reducing inflammation in AMD

A new research paper was published in Aging (Aging-US) on the cover of Volume 14, Issue 10, entitled, "Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)."

31 May 2022

Researchers discover how a workhorse protein keeps protein production on track

Cells produce proteins like little factories. But if they make too much at the wrong times it can lead to diseases like cancer, so they control production with a process called RNA interference (RNAi).

31 May 2022

Scientists develop new way to attack synovial sarcoma using an investigational drug

Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma - a rare tumor of soft tissues, such as ligaments and muscles - using an investigational drug that triggers cell death.

31 May 2022

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Millions of consumers and patients around the world will be heartened by the results of the latest study on cannabis and driving.

30 May 2022

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

The internationally renowned pharmaceutical scientist Professor Hans Lennernäs of Uppsala University has been given a Humboldt Research Award worth EUR 60,000 by the Alexander von Humboldt Foundation.

30 May 2022

Study highlights clinical features and treatment approaches for human monkeypox in the UK

researchers from the UK unveil the details of imported, household, and hospital transmission of monkeypox and report the first usage of two specific antiviral agents in the treatment of this disease.

30 May 2022

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Breast cancer and type 2 diabetes would seem to be distinctly different diseases, with commonality only in their commonality.

30 May 2022

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Researchers reported findings of a systematic antigenic analysis of the circulating SARS-CoV-2 Omicron subvariants such as BA.2.12.1, BA.4, and BA.5.

30 May 2022

UK-Argentina led resolution could lead to better protection from future pandemics

Millions of people across the world will be better protected from future pandemics thanks to a landmark resolution brought by the UK and Argentina at the World Health Assembly (WHA) in Geneva today (Friday 27 May).

27 May 2022

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

Researchers compared the polymer-nanoparticle hydrogel system and standard routes of delivery of broadly neutralizing antibodies against SARS-CoV-2 in a mouse model.

27 May 2022

New therapeutic approach harnesses the body's immune system to protect against brain damage

A therapeutic method for harnessing the body's immune system to protect against brain damage is published today by researchers from the Babraham Institute's Immunology research program.

27 May 2022

Combined treatment approach proves to be beneficial for prostate cancer patients

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy - a commonly used hormone injection - plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years.

26 May 2022

Scientists unlock a new approach to kill hard-to-treat cancers

In a paper appearing in Nature today, an international group of scientists have unlocked a new way to kill hard to treat cancers. These tumors resist current immunotherapies, including those using Nobel Prize winning check-point blocking antibodies.

26 May 2022

Researchers report novel interactions between the SARS-CoV-2 S protein and estrogen receptor alpha

Researchers profiled the binding sites of the entire SARS-CoV-2 spike protein sequence.

26 May 2022

Researchers discover mechanisms underlying T-cell receptor's immunosuppressive function

Investigators have discovered the mechanisms underlying a T-cell receptor's immunosuppressive function, according to a study published Nature Immunology, findings that may provide insight into the development of novel precision therapeutics for chronic diseases, including cancer.

25 May 2022

Researchers identify the genetic causes of three mitochondrial diseases using new approach

When something goes wrong in mitochondria, the tiny organelles that power cells, it can cause a bewildering variety of symptoms such as poor growth, fatigue and weakness, seizures, developmental and cognitive disabilities, and vision problems.

25 May 2022

Therapeutics News and Research

ASU study explores components of the immune system

New research may open a window to treating aggressive form of B-cell acute lymphoblastic leukemia

Study finds a link between aging and cancer metastases

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

Study highlights the positive effects of Humanin G in reducing inflammation in AMD

Researchers discover how a workhorse protein keeps protein production on track

Scientists develop new way to attack synovial sarcoma using an investigational drug

Highest medicinal dose of cannabidiol is driver-safe, study confirms

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

Study highlights clinical features and treatment approaches for human monkeypox in the UK

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

UK-Argentina led resolution could lead to better protection from future pandemics

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

New therapeutic approach harnesses the body's immune system to protect against brain damage

Combined treatment approach proves to be beneficial for prostate cancer patients

Scientists unlock a new approach to kill hard-to-treat cancers

Researchers report novel interactions between the SARS-CoV-2 S protein and estrogen receptor alpha

Researchers discover mechanisms underlying T-cell receptor's immunosuppressive function

Researchers identify the genetic causes of three mitochondrial diseases using new approach

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News